Treatment of Gorlin syndrome (nevoid basal cell carcinoma syndrome) with methylaminolevulinate photodynamic therapy in seven patients, including two children: Interest of tumescent anesthesia for pain control in children

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 2, 2013, Pages

  Girard, C ^a   Debu, A ^a   Bessis, D ^a   Blatiere V ^a   Dereure, O ^a   Guillot, B ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; LIDOCAINE; PARACETAMOL; ROPIVACAINE;

ADOLESCENT; ADULT; ANALGESIA; ANESTHESIA; ARTICLE; BASAL CELL NEVUS SYNDROME; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERPIGMENTATION; ILLUMINATION; MALE; NOCICEPTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION; TUMESCENT LOCAL ANESTHESIA;

ADOLESCENT; ADULT; AMINOLEVULINIC ACID; ANESTHESIA; BASAL CELL NEVUS SYNDROME; CHILD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PAIN MANAGEMENT; PHOTOCHEMOTHERAPY;

EID: 84872679352     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04538.x     Document Type: Article

References (23)

1. Gorlin RJ, Goltz RW,. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib syndrome. N Engl J Med 1960; 262: 908-912.
2. Farndon PA, Del Mastro RG, Evans DG, et al. Location of gene for Gorlin syndrome. Lancet 1992; 339: 581-582.
3. Bale AE, Yu KP,. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001; 10: 757-762.
4. Epstein E Jr,. Genetic determinants of basal cell carcinoma risk. Med Pediat Oncol 2001; 36: 555-558.
5. Gorlin RJ,. Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995; 13: 113-125.
6. O'Malley S, Weitman D, Olding M, et al. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. J Neurosurg 1997; 86: 286-288.
7. Atahan IL, Yildiz F, Ozyar E, et al. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome. Pediatr Hematol Oncol 1998; 15: 187-191.
8. Braathen LR, Szeimies RM, Basset-Seguin N, et al. International Society for Photodynamic Therapy in Dermatology Guidelines on the use of photodynamic therapy for non melanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005 J Am Acad Dermatol 2007; 56: 125-143.
9. Babilas P, Schreml S, Landthaler M, et al. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed 2010; 26: 118-132.
10. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242-1249.
11. Itkin A, Gilchrest BA,. delta-Aminolevulinic acid light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg 2004; 30: 1054-1061.
12. Oseroff AR, Shieh S, Frawley NP, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 2005; 141: 60-67.
13. Loncaster JA, Moore JV, Allan D, et al. An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy. Photodiagn Photodyn Ther 2005; 2: 149-155.
14. Mougel F, Debarbieux S, Ronger-Savlé S, et al. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy. Dermatology. 2009; 219: 138-142.
15. Loncaster J, Swindell R, Slevin F, et al. Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas. Clin Oncol (R CollRadiol) 2009; 21: 502-508.
16. Dijkstra AT, Majoie IM, Van Donjen JW, et al. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J EurAcad Dermatol Venereol 2001; 15: 550-554.
17. Rhodes LE, De Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-1136.
18. Lane JE, Allen JH, Lane TN Jr,. et al. Unilateral Basal cell carcinomas: an unusual entity treated with photodynamic therapy J Cutan Med Surg 2005; 9: 336-340.
19. Klein JA,. The tumescent technique for liposuction surgery. Am J Cosm Surg 1987; 4: 263-267.
20. Habbema L,. Safety of liposuction using exclusively tumescent local anesthesia in 3,240 consecutive cases. Dermatol Surg 2009; 35: 1728-1735.
21. Habbema L,. Efficacy of tumescent local anesthesia with variable lidocaine concentration in 3430 consecutive cases of liposuction. J Am Acad Dermatol 2010; 62: 988-994.
22. Bussolin L, Busoni P, Giorgi L, et al. Tumescent local anesthesia for the surgical treatment of burns and post burn sequelae in pediatric patients. Anesthesiology 2003; 99: 1371-1375.
23. Bussolin L, Serio P, Busoni P, et al. Plasma levels of lignocaine during tumescent local anaesthesia in children with burns. Anaesth Intensive Care 2010; 38: 1008-1012.